____________________1 Potential first-in-class radioenhancer “NBTXR3” was licensed to Johnson & Johnson by Nanobiotix in 2023 and renamed...
Reports
Skipton Business Finance (SBF) reported a 13% increase in pre-tax profit, reaching £10.8m ($13.9m) for 2024. A...
Tecelra® launch on track with 9 Authorized Treatment Centers available to initiate patient treatment journey, and the...
SAN JOSE, Calif., October 23, 2024–(BUSINESS WIRE)–QuantumScape Corporation (NYSE: QS), a leader in developing next-generation solid-state lithium-metal...
